UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations

Journal of addiction medicine, 2019-03, Vol.13 (2), p.93-103

2019

Volltextzugriff (PDF)

BUPRENORPHINE HYDROCHLORIDE INJECTION

Pharmacy times, 2020-07, Vol.86 (7), p.48

2020

Volltextzugriff (PDF)

Extended-release versus oral buprenorphine as opioid maintenance treatment during pregnancy-maternal and neonatal outcomes

European journal of obstetrics & gynecology and reproductive biology, 2024-06, Vol.297, p.106-110

2024

Volltextzugriff (PDF)

A Comparison of Buprenorphine, Sustained release Buprenorphine, and High concentration Buprenorphine in Male New Zealand White Rabbits

Journal of the American Association for Laboratory Animal Science, 2020-09, Vol.59 (5), p.546-556

2020

Volltextzugriff (PDF)

The Pharmacokinetics and Pharmacodynamics of Buprenorphine in Neonatal Abstinence Syndrome

Clinical pharmacology and therapeutics, 2018-06, Vol.103 (6), p.1029-1037

2018

Volltextzugriff (PDF)

A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates

Proceedings of the National Academy of Sciences - PNAS, 2016-09, Vol.113 (37), p.E5511-E5518

2016

Volltextzugriff (PDF)

Buprenorphine physician–pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network

Addiction (Abingdon, England), 2021-07, Vol.116 (7), p.1805-1816

2021

Volltextzugriff (PDF)

The switching process from buprenorphine sublingual tablets to the monthly buprenorphine subcutaneous depot injection in opioid dependent patients

Addiction biology, 2023-05, Vol.28 (5), p.e13275-n/a

2023

Volltextzugriff (PDF)

No Clinically Relevant Drug-Drug Interactions between Methadone or Buprenorphine-Naloxone and Antiviral Combination Glecaprevir and Pibrentasvir

Antimicrobial agents and chemotherapy, 2017-10, Vol.61 (10)

2017

Volltextzugriff (PDF)

Interactions Between Buprenorphine and the Protease Inhibitors Darunavir-Ritonavir and Fosamprenavir-Ritonavir

Clinical infectious diseases, 2012-02, Vol.54 (3), p.414-423

2012

Volltextzugriff (PDF)

Buprenorphine–Naloxone Therapy in Pain Management

Anesthesiology (Philadelphia), 2014-05, Vol.120 (5), p.1262-1274

2014

Volltextzugriff (PDF)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder

Acta obstetricia et gynecologica Scandinavica, 2023-03, Vol.102 (3), p.313-322

2023

Volltextzugriff (PDF)

Buprenorphine for managing opioid withdrawal

Cochrane database of systematic reviews, 2017-02, Vol.2 (2), p.CD002025

2017

Volltextzugriff (PDF)

Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia

Addiction (Abingdon, England), 2020-07, Vol.115 (7), p.1295-1305

2020

Volltextzugriff (PDF)

The Efficacy of Buprenorphine in Major Depression, Treatment-Resistant Depression and Suicidal Behavior: A Systematic Review

International journal of molecular sciences, 2018-08, Vol.19 (8), p.2410

2018

Volltextzugriff (PDF)

Low-dose buprenorphine initiation in the era of fentanyl and fentanyl analogs: A case series of outpatient inductions

Journal of opioid management, 2023-11, Vol.19 (5), p.455-460

2023

Volltextzugriff (PDF)

Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option

Drugs (New York, N.Y.), 2018-08, Vol.78 (12), p.1211-1228

2018

Volltextzugriff (PDF)

The association between longitudinal trends in receipt of buprenorphine for opioid use disorder and buprenorphine-waivered providers in the United States

Addiction (Abingdon, England), 2023-11, Vol.118 (11), p.2215-2219

2023

Volltextzugriff (PDF)

Characterizing acute and postsurgical pain management in patients receiving buprenorphine or buprenorphine/naloxone

Journal of the American Pharmacists Association, 2024-05, Vol.64 (3), p.102035-102035, Article 102035

2024

Volltextzugriff (PDF)

Factors Affecting Buprenorphine Utilization and Spending in Medicaid, 2002-2018

Value in health, 2021-02, Vol.24 (2), p.182-187

2021

Volltextzugriff (PDF)

Optimizing Safe Opioid Prescribing: A Paradigm Shift in Buprenorphine Management for Orthopaedic Surgery

The Journal of arthroplasty, 2024-06

2024

Volltextzugriff (PDF)

On my own terms: Motivations for self-treating opioid-use disorder with non-prescribed buprenorphine

Drug and alcohol dependence, 2020-05, Vol.210, p.107958-107958, Article 107958

2020

Volltextzugriff (PDF)

A randomised controlled trial of sublingual buprenorphine–naloxone film versus tablets in the management of opioid dependence

Drug and alcohol dependence, 2013-07, Vol.131 (1), p.119-126

2013

Volltextzugriff (PDF)

Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis

Journal of clinical psychopharmacology, 2020-05, Vol.40 (3), p.231-239

2020

Volltextzugriff (PDF)

Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users

Addiction biology, 2015-07, Vol.20 (4), p.784-798

2015

Volltextzugriff (PDF)

1 – 25 von 10.536

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(8.339)
Mit Volltextzugriff
(7.930)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(7.553)
Life Sciences & Biomedicine
(7.409)
Buprenorphine
(6.928)
Humans
(6.121)
Buprenorphine - Therapeutic Use
(3.439)
Male
(3.419)
Female
(3.306)
Substance Abuse
(2.890)
Narcotics
(2.748)
Adult
(2.543)
Opioid-Related Disorders - Drug Therapy
(2.391)
Opioids
(2.320)
Methadone
(2.264)
Buprenorphine - Administration & Dosage
(1.854)
Psychiatry
(1.719)
Drug Addiction
(1.574)
Middle Aged
(1.539)
Substance Abuse Treatment
(1.498)
Analgesics, Opioid - Therapeutic Use
(1.456)
Drug Abuse
(1.331)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(7.205)
Ingenta Connect
(4.493)
Journals@Ovid Complete
(3.923)
EZB Electronic Journals Library
(3.199)
IngentaConnect Journals
(2.558)
Elsevier ScienceDirect Journals Complete
(2.158)
Wiley Blackwell Single Titles
(2.048)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.679)
Wiley Online Library
(1.589)
Applied Social Sciences Index & Abstracts (ASSIA)
(1.544)
Single Journals
(1.361)
Taylor & Francis:Master (3349 titles)
(996)
Taylor & Francis Journals
(967)
SpringerLink_现刊
(927)
EBSCOhost Psychology and Behavioral Sciences Collection
(894)
Taylor & Francis Current Content Access
(793)
SAGE Journals
(458)
Sociological Abstracts
(376)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(349)
Oxford Journals
(226)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(57)
... seit 30 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations

BUPRENORPHINE HYDROCHLORIDE INJECTION

Extended-release versus oral buprenorphine as opioid maintenance treatment during pregnancy-maternal and neonatal outcomes

A Comparison of Buprenorphine, Sustained release Buprenorphine, and High concentration Buprenorphine in Male New Zealand White Rabbits

The Pharmacokinetics and Pharmacodynamics of Buprenorphine in Neonatal Abstinence Syndrome

A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates

Buprenorphine physician–pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network

The switching process from buprenorphine sublingual tablets to the monthly buprenorphine subcutaneous depot injection in opioid dependent patients

No Clinically Relevant Drug-Drug Interactions between Methadone or Buprenorphine-Naloxone and Antiviral Combination Glecaprevir and Pibrentasvir

Interactions Between Buprenorphine and the Protease Inhibitors Darunavir-Ritonavir and Fosamprenavir-Ritonavir

Buprenorphine–Naloxone Therapy in Pain Management

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder

Buprenorphine for managing opioid withdrawal

Perceptions of extended‐release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia

The Efficacy of Buprenorphine in Major Depression, Treatment-Resistant Depression and Suicidal Behavior: A Systematic Review

Low-dose buprenorphine initiation in the era of fentanyl and fentanyl analogs: A case series of outpatient inductions

Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option

The association between longitudinal trends in receipt of buprenorphine for opioid use disorder and buprenorphine-waivered providers in the United States

Characterizing acute and postsurgical pain management in patients receiving buprenorphine or buprenorphine/naloxone

Factors Affecting Buprenorphine Utilization and Spending in Medicaid, 2002-2018

Optimizing Safe Opioid Prescribing: A Paradigm Shift in Buprenorphine Management for Orthopaedic Surgery

On my own terms: Motivations for self-treating opioid-use disorder with non-prescribed buprenorphine

A randomised controlled trial of sublingual buprenorphine–naloxone film versus tablets in the management of opioid dependence

Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis

Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users

Suchergebnisse filtern